Talquetamab (JNJ-64407564) is a T-cell retargeting GPRC5D bispecific antibody for multiple myeloma with antitumor activity that induces T-cell-mediated killing of GPRC5-expressing MM cells through T-cell recruitment and activation.Talquetamab is used to
CAS Nummer:
[2226212-40-2]
Target-Kategorie:
JNJ-64407564 , JNJ-7564
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten